Identification of a novel mutation in the dihydropyrimidine dehydrogenase gene in a patient with a lethal outcome following 5-fluorouracil administration and the determination of its frequency in a population of 500 patients with colorectal carcinoma
Author:
Publisher
Elsevier BV
Subject
Clinical Biochemistry,General Medicine
Reference35 articles.
1. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study;de Gramont;J. Clin. Oncol.,1997
2. Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial;Andre;J. Clin. Oncol.,2003
3. Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity;Tuchman;N. Engl. J. Med.,1985
4. Familial deficiency of dihydropyrimidine dehydrogenase (biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity);Diasio;J. Clin. Invest.,1988
5. Dihydropyrimidine dehydrogenase: its role in 5-fluorouracil clinical toxicity and tumor resistance;Diasio;Clin. Cancer Res.,1999
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. DPYDgenetic polymorphisms in non-European patients with severe fluoropyrimidine-related toxicity: A systematic review;2023-12-11
2. Initiation of the Pharmacogenetics of Capecitabine in Morocco;Current Cancer Therapy Reviews;2022-11
3. After thirty years of experience with early postoperative intraperitoneal 5-fluorouracil now saying goodbye;Surgical Oncology;2022-06
4. Comparison of 4 Screening Methods for Detecting Fluoropyrimidine Toxicity Risk: Identification of the Most Effective, Cost-Efficient Method to Save Lives;Dose-Response;2020-07-01
5. Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer;Current Pharmaceutical Design;2018-10-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3